IP vs MIRM · P/E 43, $26.62B cap vs rev $336.9M
International Paper (IP) versus Mirum Pharmaceuticals Inc (MIRM) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Mirum Pharmaceuticals Inc (MIRM) is a biotechnology company listed on NASDAQ.
IP does not have a complete income-statement cache yet.
Latest reported MIRM revenue for 2024-12-31 was $336.9M. Net income was -$87.9M. Revenue was up 80.8% from 2023-12-31 to 2024-12-31. MIRM currently screens at market cap $6.22B.
IP currently screens at market cap $26.62B and trailing P/E 43.1. MIRM currently screens at market cap $6.22B.
Not investment advice. Open the IP and MIRM stock pages for the full models.
Not investment advice.